U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.
The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer. That pill is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.
Read more: [ Ссылка ]
![](https://s2.save4k.ru/pic/BGCYXOxvLWA/maxresdefault.jpg)